526 related articles for article (PubMed ID: 28852896)
1. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
2. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
3. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
4. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
5. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
7. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
8. Assessing hydroxychloroquine toxicity by the multifocal ERG.
Moschos MN; Moschos MM; Apostolopoulos M; Mallias JA; Bouros C; Theodossiadis GP
Doc Ophthalmol; 2004 Jan; 108(1):47-53. PubMed ID: 15104166
[TBL] [Abstract][Full Text] [Related]
9. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
[TBL] [Abstract][Full Text] [Related]
10. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
Lai TY; Chan WM; Li H; Lai RY; Lam DS
Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
[TBL] [Abstract][Full Text] [Related]
11. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
12. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
13. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine retinopathy: an emerging problem.
Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
[TBL] [Abstract][Full Text] [Related]
15. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ
Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
Ahn SJ; Lee SU; Lee SH; Lee BR
Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
[TBL] [Abstract][Full Text] [Related]
17. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
[TBL] [Abstract][Full Text] [Related]
18. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
19. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
20. New proposal for a multimodal imaging approach for the subclinical detection of hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus.
Araújo O; Casaroli-Marano RP; Hernández-Rodríguez J; Figueras-Roca M; Budi V; Morató M; Hernández-Negrín H; Ríos J; Adan A; Espinosa G; Pelegrín L; Cervera R
BMJ Open Ophthalmol; 2024 Mar; 9(1):. PubMed ID: 38499344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]